Jacob Joseph

6.2k total citations
132 papers, 3.1k citations indexed

About

Jacob Joseph is a scholar working on Cardiology and Cardiovascular Medicine, Rheumatology and Surgery. According to data from OpenAlex, Jacob Joseph has authored 132 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Cardiology and Cardiovascular Medicine, 21 papers in Rheumatology and 18 papers in Surgery. Recurrent topics in Jacob Joseph's work include Heart Failure Treatment and Management (32 papers), Cardiovascular Function and Risk Factors (21 papers) and Folate and B Vitamins Research (14 papers). Jacob Joseph is often cited by papers focused on Heart Failure Treatment and Management (32 papers), Cardiovascular Function and Risk Factors (21 papers) and Folate and B Vitamins Research (14 papers). Jacob Joseph collaborates with scholars based in United States, Canada and United Kingdom. Jacob Joseph's co-authors include Joseph Loscalzo, Lija Joseph, Richard H. Kennedy, Martin Hauer‐Jensen, Diane E. Handy, Yash Patel, Jennifer Furin, Sonya Shin, Jawahar L. Mehta and Sulochana Devi and has published in prestigious journals such as The Lancet, JAMA and Nucleic Acids Research.

In The Last Decade

Jacob Joseph

127 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacob Joseph United States 32 904 598 570 547 533 132 3.1k
Ettore Porreca Italy 36 1.1k 1.3× 662 1.1× 453 0.8× 676 1.2× 383 0.7× 132 4.0k
Alessandro Di Minno Italy 31 737 0.8× 453 0.8× 379 0.7× 580 1.1× 209 0.4× 125 3.0k
Κimon Stamatelopoulos Greece 36 1.5k 1.7× 421 0.7× 466 0.8× 824 1.5× 437 0.8× 166 4.2k
Roberto Cangemi Italy 37 1.1k 1.2× 532 0.9× 844 1.5× 426 0.8× 547 1.0× 114 3.6k
Seong Kwon South Korea 32 592 0.7× 485 0.8× 352 0.6× 774 1.4× 105 0.2× 243 3.4k
Benjamín Van Tassell United States 31 1.3k 1.4× 493 0.8× 391 0.7× 926 1.7× 554 1.0× 113 3.3k
Alise Reicin United States 27 1.4k 1.5× 1.2k 2.0× 162 0.3× 499 0.9× 197 0.4× 39 5.7k
Benjamin Dieplinger Austria 36 1.3k 1.5× 1000 1.7× 369 0.6× 506 0.9× 147 0.3× 99 3.5k
Anneke C. Muller Kobold Netherlands 37 412 0.5× 641 1.1× 557 1.0× 588 1.1× 136 0.3× 123 3.5k
Marie‐Anne Loriot France 44 244 0.3× 452 0.8× 1.2k 2.1× 1.3k 2.5× 425 0.8× 159 5.8k

Countries citing papers authored by Jacob Joseph

Since Specialization
Citations

This map shows the geographic impact of Jacob Joseph's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob Joseph with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob Joseph more than expected).

Fields of papers citing papers by Jacob Joseph

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob Joseph. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob Joseph. The network helps show where Jacob Joseph may publish in the future.

Co-authorship network of co-authors of Jacob Joseph

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob Joseph. A scholar is included among the top collaborators of Jacob Joseph based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob Joseph. Jacob Joseph is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Joseph, Jacob, et al.. (2025). Atrial Fibrillation Recurrence Post-Ablation Across Heart Failure Categories: A Systematic Review and Meta-analysis. Cardiology Research. 16(1). 33–43. 1 indexed citations
2.
Kurgansky, Katherine E., et al.. (2024). Spironolactone Reduces the Risk of Death in Veterans With Heart Failure With Preserved Ejection Fraction. Journal of the American Heart Association. 13(14). e032231–e032231. 1 indexed citations
3.
Liu, Chang, Qin Hui, Quinn S. Wells, et al.. (2024). A Multivariable Mendelian Randomization Study of Systolic and Diastolic Blood Pressure, Lipid Profile, and Heart Failure Subtypes. Genes. 15(9). 1126–1126. 1 indexed citations
4.
Joseph, Jacob, et al.. (2024). Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta‐analysis. Journal of Cardiovascular Electrophysiology. 35(4). 715–726. 5 indexed citations
5.
Joseph, Jacob, et al.. (2024). Barriers To E-Governance Adoption in Rural and Marginalized Communities: Challenges and Strategies for Digital Inclusion. International Research Journal on Advanced Engineering and Management (IRJAEM). 2(12). 3809–3817. 1 indexed citations
6.
Sun, Yan V., Chang Liu, Qin Hui, et al.. (2024). Identification and correction for collider bias in a genome-wide association study of diabetes-related heart failure. The American Journal of Human Genetics. 111(7). 1481–1493. 2 indexed citations
7.
Liu, Chang, Qin Hui, Jin Zhou, et al.. (2024). High Variability of Body Mass Index Is Independently Associated With Incident Heart Failure. Journal of the American Heart Association. 13(9). e031861–e031861.
8.
Joseph, Jacob, Chang Liu, Qin Hui, et al.. (2022). Genetic architecture of heart failure with preserved versus reduced ejection fraction. Nature Communications. 13(1). 32 indexed citations
9.
Mossialos, Elías, Ariela R. Orkaby, Jacob Joseph, et al.. (2022). Challenges for Patients Dying of Heart Failure and Cancer. Circulation Heart Failure. 15(12). e009922–e009922. 4 indexed citations
10.
Andersson, Charlotte, Morten Schou, William E. Boden, et al.. (2022). Trends in Ischemic Evaluation in New-Onset Heart Failure Without Known Coronary Artery Disease. JACC Heart Failure. 10(11). 807–815. 6 indexed citations
11.
Rubinstein, Jack, Nathan Robbins, Karen K. Evans, et al.. (2022). Repurposing Probenecid for the Treatment of Heart Failure (Re-Prosper-HF): a study protocol for a randomized placebo-controlled clinical trial. Trials. 23(1). 266–266. 3 indexed citations
12.
Gaziano, Liam, Kelly Cho, Luc Djoussé, et al.. (2021). Risk Factors and Prediction Models for Incident Heart Failure with Reduced and Preserved Ejection Fraction. ESC Heart Failure. 8(6). 4893–4903. 17 indexed citations
13.
Joseph, Jacob, Brian Claggett, Inder S. Anand, et al.. (2016). QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection Fraction. JACC Heart Failure. 4(6). 477–486. 36 indexed citations
14.
Forman, Daniel E., Karla M. Daniels, Lawrence P. Cahalin, et al.. (2014). Analysis of Skeletal Muscle Gene Expression Patterns and the Impact of Functional Capacity in Patients With Systolic Heart Failure. Journal of Cardiac Failure. 20(6). 422–430. 20 indexed citations
15.
Becerra, Mercedes C., Molly F. Franke, Sasha C. Appleton, et al.. (2012). Tuberculosis in Children Exposed at Home to Multidrug-resistant Tuberculosis. The Pediatric Infectious Disease Journal. 32(2). 115–119. 24 indexed citations
16.
Joseph, Jacob, et al.. (2012). Lay Health Workers and HIV Care in Rural Lesotho: A Report from the Field. AIDS Patient Care and STDs. 26(3). 141–147. 21 indexed citations
18.
Joseph, Jacob. (2010). Mast Cells and Cardiovascular Disease. Nova Science Publishers eBooks. 1 indexed citations
19.
Kennedy, Richard H., et al.. (2004). Acute negative inotropic effects of homocysteine are mediated via the endothelium. American Journal of Physiology-Heart and Circulatory Physiology. 287(2). H812–H817. 31 indexed citations
20.
Joseph, Jacob & Edward M. Gilbert. (1998). The sympathetic nervous system in chronic heart failure. Progress in Cardiovascular Diseases. 41(1). 9–16. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026